Skip to main content

Research Repository

Advanced Search

Unsafe "crossover-use" of chloramphenicol in Uganda: importance of a One Health approach in antimicrobial resistance policy and regulatory action

McCubbin, KD; Ramatowski, JW; Buregyeya, E; Hutchinson, E; Kaur, H; Mbonye, AK; Mateus, ALP; Clarke, SE

Authors

KD McCubbin

JW Ramatowski

E Buregyeya

E Hutchinson

H Kaur

AK Mbonye

ALP Mateus

SE Clarke



Abstract

Since the introduction of antibiotics into mainstream health care, resistance to these drugs has become a widespread issue that continues to increase worldwide. Policy decisions to mitigate the development of antimicrobial resistance are hampered by the current lack of surveillance data on antibiotic product availability and use in low-income countries. This study collected data on the antibiotics stocked in human (42) and veterinary (21) drug shops in five sub-counties in Luwero district of Uganda. Focus group discussions with drug shop vendors were also employed to explore antibiotic use practices in the community. Focus group participants reported that farmers used human-intended antibiotics for their livestock, and community members obtain animal-intended antibiotics for their own personal human use. Specifically, chloramphenicol products licensed for human use were being administered to Ugandan poultry. Human consumption of chloramphenicol residues through local animal products represents a serious public health concern. By limiting the health sector scope of antimicrobial resistance research to either human or animal antibiotic use, results can falsely inform policy and intervention strategies. Therefore, a One Health approach is required to understand the wider impact of community antibiotic use and improve overall effectiveness of intervention policy and regulatory action.

Citation

McCubbin, K., Ramatowski, J., Buregyeya, E., Hutchinson, E., Kaur, H., Mbonye, A., …Clarke, S. (2021). Unsafe "crossover-use" of chloramphenicol in Uganda: importance of a One Health approach in antimicrobial resistance policy and regulatory action. Journal of Antibiotics, 74(6), 417-420. https://doi.org/10.1038/s41429-021-00416-3

Journal Article Type Article
Acceptance Date Mar 18, 2021
Publication Date 2021
Deposit Date Dec 15, 2021
Publicly Available Date Dec 15, 2021
Print ISSN 0021-8820
Publisher Springer Nature [academic journals on nature.com]
Peer Reviewed Peer Reviewed
Volume 74
Issue 6
Pages 417-420
DOI https://doi.org/10.1038/s41429-021-00416-3
Public URL https://rvc-repository.worktribe.com/output/1553311

Files




Downloadable Citations